Physiomics PLC

Here is the public summary page for Physiomics PLC. Please login to see the complete information for Physiomics PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Physiomics PLC stacks up relative to its peers.


Darwin Score-3
TickerPYC
Latest Price0.00 GBP as of close on 28-Jul-2025
3 Month price range0.00 to 0.01 GBP
Market Capitalisation1.26Mn GBP
CountryUnited Great Britain and Northern Ireland
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
See More ...
Company URLhttps://www.physiomics.co.uk
See Darwins Full Analysis for Physiomics PLC

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Physiomics PLC. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-13
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.+1
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+7

Peer Comparison

There are 4 peers of Physiomics PLC.
Asset NameIndustry GroupPerf(20d)%Asset Score
Angle PLC (AGL)Biotechnology-20.0-29
Arecor Therapeutics PLC (AREC)Biotechnology+27.6+4
Haleon PLC (HLN)Biotechnology-2.8+21
Shield Therapeutics PLC (STX)Biotechnology+54.8+15

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn